UK markets closed

AnaptysBio, Inc. (0HFQ.L)

LSE - LSE Delayed price. Currency in USD
Add to watchlist
86.95+63.88 (+276.93%)
At close: 03:23PM BST
Currency in USD

Valuation measures4

Market cap (intra-day) N/A
Enterprise value N/A
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue N/A
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 0.19
52-week change 3N/A
S&P500 52-week change 3-13.03%
52-week high 324.12
52-week low 324.12
50-day moving average 3N/A
200-day moving average 3N/A

Share statistics

Avg vol (3-month) 3N/A
Avg vol (10-day) 3N/A
Shares outstanding 526.75M
Implied shares outstanding 6N/A
Float 817.95M
% held by insiders 10.35%
% held by institutions 1109.67%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 4N/A
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2021
Most-recent quarter (mrq)31 Mar 2022


Profit margin -143.46%
Operating margin (ttm)-126.66%

Management effectiveness

Return on assets (ttm)-8.20%
Return on equity (ttm)-21.30%

Income statement

Revenue (ttm)52.9M
Revenue per share (ttm)1.92
Quarterly revenue growth (yoy)-91.40%
Gross profit (ttm)-35.32M
EBITDA -66.35M
Net income avi to common (ttm)-75.89M
Diluted EPS (ttm)-2.76
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)505.62M
Total cash per share (mrq)17.94
Total debt (mrq)20.6M
Total debt/equity (mrq)6.23
Current ratio (mrq)25.90
Book value per share (mrq)11.74

Cash flow statement

Operating cash flow (ttm)-43.73M
Levered free cash flow (ttm)-20.79M